daVinci Digital Therapeutics is an innovative company that designs, develops through clinical trials and markets evidence-based digital therapies for clinically and socially relevant diseases to the benefit of patients worldwide. Digital Therapeutics that provide patients with proven and documented clinical benefits.
daVinci Digital Therapeutics’ initial areas of research and development are depression and eating disorders, involving patients and healthcare professionals in the development of its digital therapeutics.
daVinci Digital Therapeutics cooperates with patients and physicians, scientific associations, healthcare organizations and institutions to allow digital therapies to represent a new era of medical therapy, offering patients new hopes for care and improvement of their disease.
Digital Therapeutics #DTx are an emerging class of medicines that deliver evidence-based therapeutic interventions to patients. In a similar way to the drug, we can
Milan and London – November 13, 2019 Digital Therapeutics are an emerging class of medical interventions to treat chronic diseases and dependence daVinci Digital Therapeutics
Raising awareness about digital therapy, helping to clarify the pathway to reimbursement and integration into healthcare.
Chairpersons: Roberto Ascione, Massimo Beccaria, Giuseppe Recchia, Eugenio Santoro.
28 May 2019 @ Polihub, Arena Meeting Room Via Durando 39, Milan
Engineer from the Politecnico of Milan, with over 15 years of experience in multinational medical device companies and management of advanced technology companies.
Medical Doctor, with over 35 years of experience in medical research, development of drugs and advanced technologies in a pharmaceutical company and a scientific foundation
Psychiatrist and leading science blogger, with clinical experience in mental health disorders and skills in advanced digital technology and communication
2019 © daVinci Digital Therapeutics Srl – P.IVA 10664440962 – Privacy